Pharmacological properties of an extremely selective beta 1-adrenoceptor antagonist, 2-[4-[3-(tert-Butylamino)-2-hydroxypropoxy] phenyl]-3-methyl-6-methoxy-4(3H)-quinazolinone [+/-)HX-CH 44 BS).
2-[4-[3-(tert-Butylamino)-2-hydroxypropoxy] phenyl]-3-methyl-6-methoxy-4(3H)-quinazolinone (+/-)HX-CH 44 BS) is a new beta 1-selective adrenoceptor antagonist. Affinity for beta 1-adrenoceptors was determined in isolated guinea-pig papillary muscle (pA2 = 7.4), in isoprenaline-stimulated guinea-pig cardiac adenylate cyclase (pA2 = 7.3) and in receptor binding experiments with rat heart membranes (pKi = 8.0). Due to a direct relaxing action of (+/-)HX-CH 44 in smooth muscles its beta 2-affinity could only be estimated from receptor binding experiments (pKi = 5.0). (+/-)HX-CH 44 BS shows an extremely high beta 1/beta 2-affinity ratio of about 800 and therefore appears to be much more selective than atenolol or metoprolol (beta 1/beta 2 = 10-50). In contrast to propranolol or atenolol, (+/-)HX-CH 44 hardly antagonized bronchodilation induced by i.v. isoproterenol in anaesthetized guinea-pigs in vivo. Furthermore, cardiac actions of the beta 1-selective agonist norepinephrine in cats in vivo were competitively antagonized by (+/-)HX-CH 44 whereas inotropic and chronotropic effects of the non-selective beta-agonist epinephrine were not. This phenomenon may be explained by the mixed population of beta 1-and beta 2-adrenoceptors in cat heart and by the high beta 1-selectivity of (+/-)HX-CH 44.